Leucettamol A: a new inhibitor of Ubc13-Uev1A interaction isolated from a marine sponge, Leucetta aff. microrhaphis

Bioorg Med Chem Lett. 2008 Dec 15;18(24):6319-20. doi: 10.1016/j.bmcl.2008.10.110. Epub 2008 Oct 31.

Abstract

A compound that inhibits the formation of a complex composed of the ubiquitin E2 enzyme Ubc13 and Uev1A was isolated from the marine sponge Leucetta aff. microrhaphis. The compound was identified as leucettamol A (1) by spectroscopic analysis. Its inhibition of Ubc13-Uev1A interaction was tested by the ELISA method, revealing an IC(50) value of 50 microg/mL. The compound is the first inhibitor of Ubc13-Uev1A interaction, that is, that of the E2 activity of Ubc13. Such inhibitors are presumed to be leads for anti-cancer agents that upregulate activity of the tumor suppressor p53 protein. Interestingly, hydrogenation of 1 increased its inhibitory activity with an IC(50) value of 4 microg/mL, while its tetraacetate derivative was inactive, indicating that the hydroxy and/or amino groups of 1 are required for the inhibition.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / pharmacology*
  • Crystallography, X-Ray / methods
  • Dimerization
  • Drug Screening Assays, Antitumor
  • Gene Expression Regulation, Neoplastic*
  • Genes, p53
  • Humans
  • Inhibitory Concentration 50
  • Models, Chemical
  • Porifera / drug effects
  • Porifera / metabolism*
  • Recombinant Proteins / chemistry
  • Sphingolipids / chemical synthesis
  • Sphingolipids / pharmacology*
  • Transcription Factors / antagonists & inhibitors*
  • Tumor Suppressor Protein p53 / metabolism
  • Ubiquitin-Conjugating Enzymes / antagonists & inhibitors*

Substances

  • Antineoplastic Agents
  • Recombinant Proteins
  • Sphingolipids
  • TP53 protein, human
  • Transcription Factors
  • Tumor Suppressor Protein p53
  • leucettamol A
  • UBE2N protein, human
  • UBE2V1 protein, human
  • Ubiquitin-Conjugating Enzymes